Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jessica L Goren, Pharm.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Steinauer LM, Leung JG, Burkey BW, McGrane IR, Letts V, Goren JL, Hoeft DM, Mullen S, Maroney M, Schak KM, Vande Voort JL. A Retrospective Multicenter Evaluation of Clozapine Use in Pediatric Patients Admitted for Acute Psychiatric Hospitalization. J Child Adolesc Psychopharmacol. 2018 11; 28(9):615-619. PMID: 30358422.
    Citations:    Fields:    
  2. Gören JL, Rose AJ, Ney JP. The Business Case for Expanded Clozapine Utilization: In Reply. Psychiatr Serv. 2017 03 01; 68(3):309-310. PMID: 28240155.
    Citations:    Fields:    Translation:Humans
  3. Gören JL. Brain-derived neurotrophic factor and schizophrenia. Ment Health Clin. 2016 Nov; 6(6):285-288. PMID: 29955483.
    Citations:    
  4. Gören JL, Rose AJ, Engle RL, Smith EG, Christopher ML, Rickles NM, Semla TP, McCullough MB. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine. Psychiatr Serv. 2016 11 01; 67(11):1189-1196. PMID: 27301765.
    Citations: 1     Fields:    Translation:Humans
  5. Gören JL, Rose AJ, Smith EG, Ney JP. The Business Case for Expanded Clozapine Utilization. Psychiatr Serv. 2016 11 01; 67(11):1197-1205. PMID: 27301766.
    Citations:    Fields:    Translation:Humans
  6. Huang H, Gören JL, Chan YF, Katon W, Russo J, Hogan D, Unützer J. Pharmacologic management of bipolar disorder in a Medicare Advantage population. Psychosomatics. 2014 Nov-Dec; 55(6):572-7. PMID: 25016355.
    Citations: 2     Fields:    Translation:Humans
  7. Leung JG, Nelson S, Takala CR, Gören JL. Infection and inflammation leading to clozapine toxicity and intensive care: a case series. Ann Pharmacother. 2014 Jun; 48(6):801-5. PMID: 24619948.
    Citations: 4     Fields:    Translation:Humans
  8. Gören JL, Meterko M, Williams S, Young GJ, Baker E, Chou CH, Kilbourne AM, Bauer MS. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia. Psychiatr Serv. 2013 Jun; 64(6):527-33. PMID: 23450334.
    Citations: 7     Fields:    Translation:Humans
  9. Gören JL, Dinh TA. Psychotropics and sudden cardiac death. R I Med J (2013). 2013 Mar 01; 96(3):38-41. PMID: 23641438.
    Citations: 1     Fields:    Translation:Humans
  10. Gören JL, Tewksbury AT. The use of omega-3 fatty acids in mental illness. J Pharm Pract. 2011 Oct; 24(5):452-71. PMID: 21940602.
    Citations: 2     Fields:    Translation:Humans
  11. Givon L, Porter S, Padmanabhan B, Goren J, Cohen PA. Levetiracetam, seizures, and suicidality. Harv Rev Psychiatry. 2011 Jan-Feb; 19(1):47-55. PMID: 21250896.
    Citations: 1     Fields:    Translation:Humans
  12. Gören JL, Beck SE, Mills BJ, Shtasel DL, Dufresne RL. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy. J Manag Care Pharm. 2010 Jul-Aug; 16(6):393-401. PMID: 20635830.
    Citations: 3     Fields:    Translation:Humans
  13. Gören JL, Parks JJ, Ghinassi FA, Milton CG, Oldham JM, Hernandez P, Chan J, Hermann RC. When is antipsychotic polypharmacy supported by research evidence? Implications for QI. Jt Comm J Qual Patient Saf. 2008 Oct; 34(10):571-82. PMID: 18947117.
    Citations: 11     Fields:    Translation:Humans
  14. Skeffington P, Akus M, Goren J. Expanding pharmacy services in a health system through partnership with a college of pharmacy. Am J Health Syst Pharm. 2007 May 01; 64(9):925-6. PMID: 17468144.
    Citations: 1     Fields:    Translation:Humans
  15. Gören JL. Hyperthyroidism associated with topiramate treatment. Psychosomatics. 2006 Nov-Dec; 47(6):529-30. PMID: 17116957.
    Citations:    Fields:    Translation:Humans
  16. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004 Apr; 161(4):700-6. PMID: 15056517.
    Citations: 48     Fields:    Translation:Humans
  17. Silveri MM, Parow AM, Villafuerte RA, Damico KE, Goren J, Stoll AL, Cohen BM, Renshaw PF. S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biol Psychiatry. 2003 Oct 15; 54(8):833-9. PMID: 14550683.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  18. Centorrino F, Eakin M, Bahk WM, Kelleher JP, Goren J, Salvatore P, Egli S, Baldessarini RJ. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry. 2002 Nov; 159(11):1932-5. PMID: 12411232.
    Citations: 14     Fields:    Translation:Humans
  19. Goren JL, Levin GM. Mania with bupropion: a dose-related phenomenon? Ann Pharmacother. 2000 May; 34(5):619-21. PMID: 10852090.
    Citations: 2     Fields:    Translation:Humans
  20. Goren JL, Levin GM. Quetiapine, an atypical antipsychotic. Pharmacotherapy. 1998 Nov-Dec; 18(6):1183-94. PMID: 9855315.
    Citations: 9     Fields:    Translation:Humans
  21. Goren JL, Friedman JH. Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease. Neurology. 1998 Mar; 50(3):823. PMID: 9521290.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Goren's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (101)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.